One-Year Clinical Outcomes between Single- versus Multi-Staged PCI for ST Elevation Myocardial Infarction with Multi-Vessel Coronary Artery Disease: from Korea Acute Myocardial Infarction Registry-National Institute of Health (KAMIR-NIH)

Ahn, Kye Taek; Oh, Jin Kyung; Seong, Seok-Woo; Jin, Si Hyung; Lee, Jae‐Hwan; Choi, Si Wan; Jeong, Myung Ho; Chae, Shung Chull; Kim, Young Jo; Kim, Chong Jin; Kim, Hyo Soo; Cho, Myeong Chan; Gwon, Hyeon Cheol; Jeong, Jin Ok; Seong, In Whan

doi:10.4070/kcj.2019.0176

Cited by 5 publications

(4 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A study of 606 patients with STEMI and multivessel disease from the KAMIR-NIH registry who underwent complete revascularization found that multivessel multi-staged PCI was associated with better clinical outcomes than multivessel single-staged PCI (HR, 0.42; 95% CI, 0.19–0.92; p=0.030). 60) …”

Section: Part 3 Revascularization Strategy For Non-culprit Lesions In Acute Myocardial Infarctionmentioning

confidence: 99%

2021 Korean Society of Myocardial Infarction Expert Consensus Document on Revascularization for Acute Myocardial Infarction

et al. 2021

Self Cite

View full text Add to dashboard Cite

Author's summary The characteristics of patients with acute myocardial infarction (AMI) and its disease patterns in Korea have gradually changed, and revascularization practices have also improved dramatically. Several characteristics associated with revascularization in Korean patients differ from those in other countries. The sophisticated methods of AMI revascularization have led to the need for an expert consensus among interventional cardiologists in Korea. The Task Force on Expert Consensus Document of the Korean Society of Myocardial Infarction has comprehensively reviewed previous literature, and this comprehensive review led to the development of expert consensus.

show abstract

Section: Part 3 Revascularization Strategy For Non-culprit Lesions In Acute Myocardial Infarctionmentioning

confidence: 99%

2021 Korean Society of Myocardial Infarction Expert Consensus Document on Revascularization for Acute Myocardial Infarction

et al. 2021

Self Cite

View full text Add to dashboard Cite

show abstract

“…Death resulting from causes besides cardiac ones was considered a non-cardiac death. [20] Regarding comparative analysis, continuous variables were compared using Student t test or the Wilcoxon rank-sum test, whereas categorical variables were compared using the χ 2 or Fisher exact test.…”

Section: Methodsmentioning

confidence: 99%

Adjusted mortality of extracorporeal membrane oxygenation for acute myocardial infarction patients in cardiogenic shock

et al. 2023

Self Cite

View full text Add to dashboard Cite

Cardiogenic shock (CS) is a common cause of death following acute myocardial infarction (MI). This study aimed to evaluate the adjusted mortality of venoarterial extracorporeal membrane oxygenation (VA-ECMO) with intra-aortic balloon counterpulsation (IABP) for patients with MI-CS. We included 300 MI patients selected from a multinational registry and categorized into VA-ECMO + IABP (N = 39) and no VA-ECMO (medical management ± IABP) (N = 261) groups. Both groups’ 30-day and 1-year mortality were compared using the weighted Kaplan–Meier, propensity score, and inverse probability of treatment weighting methods. Adjusted incidences of 30-day (VA-ECMO + IABP vs No VA-ECMO, 77.7% vs 50.7; P = .083) and 1-year mortality (92.3% vs 84.8%; P = .223) along with propensity-adjusted and inverse probability of treatment weighting models in 30-day (hazard ratio [HR], 1.57; 95% confidence interval [CI], 0.92–2.77; P = .346 and HR, 1.44; 95% CI, 0.42–3.17; P = .452, respectively) and 1-year mortality (HR, 1.56; 95% CI, 0.95–2.56; P = .076 and HR, 1.33; 95% CI, 0.57–3.06; P = .51, respectively) did not differ between the groups. However, better survival benefit 30 days post-ECMO could be supposed (31.6% vs 83.4%; P = .022). Therefore, patients with MI-CS treated with IABP with additional VA-ECMO and those not supported with ECMO have comparable overall 30-day and 1-year mortality risks. However, VA-ECMO-supported survivors might have better long-term clinical outcomes.

show abstract

“…In another study with second generation stents, complete revascularization strategy also showed better outcomes with reduction of 44% of cardiovascular death than culprit lesion only PCI in STEMI patients with multi vessel disease. 2) However, there have been issued regarding interval of 2nd PCI of the remaining lesions to achieve complete revascularization after the treatment of culprit lesion.In this current issue, Ahn et al 3) investigated the optimal timing of non-culprit lesions PCI by using Korea Acute Myocardial Infarction Registry-National Institute of Health (KAMIR-NIH) data. A total of 606 patients with STEMI and multi-vessel coronary artery disease underwent complete revascularization including non-culprit lesions with significant stenosis.…”

mentioning

confidence: 99%

“…In this current issue, Ahn et al 3) investigated the optimal timing of non-culprit lesions PCI by using Korea Acute Myocardial Infarction Registry-National Institute of Health (KAMIR-NIH) data. A total of 606 patients with STEMI and multi-vessel coronary artery disease underwent complete revascularization including non-culprit lesions with significant stenosis.…”

mentioning

confidence: 99%

Optimal Timing of Coronary Intervention in Non-Culprit Lesion in ST Elevation Myocardial Infarction with Multi-Vessel Disease

Seo

Kim

2020

Korean Circ J

View full text Add to dashboard Cite

Primary percutaneous coronary intervention (PCI) is a mainstay treatment option for patients with ST elevation myocardial infarction (STEMI). According to the previous studies, more than 50% of patients with STEMI have a multi-vessel disease (MVD). The culprit lesion for primary PCI can be identified by electrocardiography (ECG), echocardiography, coronary angiography (CAG) and clinical features. In most cases, the culprit lesion should be treated in the setting of primary PCI. However, there have been issues for the strategy for remaining non-culprit lesion regarding timing to perform a PCI.Previous studies have shown complete revascularization is associated with better prognosis compared with culprit lesion only PCI in patients with STEMI. In the Preventive Angioplasty in Acute Myocardial Infarction (PRAMI) trial, 1) preventive PCI in non-infarct-related coronary arteries with significant stenosis was associated with 65% reduction of cardiovascular death, myocardial infarction (MI) and refractory angina. In another study with second generation stents, complete revascularization strategy also showed better outcomes with reduction of 44% of cardiovascular death than culprit lesion only PCI in STEMI patients with multi vessel disease. 2) However, there have been issued regarding interval of 2nd PCI of the remaining lesions to achieve complete revascularization after the treatment of culprit lesion.In this current issue, Ahn et al. 3) investigated the optimal timing of non-culprit lesions PCI by using Korea Acute Myocardial Infarction Registry-National Institute of Health (KAMIR-NIH) data. A total of 606 patients with STEMI and multi-vessel coronary artery disease underwent complete revascularization including non-culprit lesions with significant stenosis. Authors compared 1-year clinical outcomes between multi-vessel single-stage PCI (SS PCI) group (n=325) and multi-vessel multi-staged PCI (MS PCI) group (n=195). At 1 year, MS PCI group showed a lower rate of all-cause mortality (hazard ratio [HR], 0.42; 95% confidence interval [CI], 0.19-0.92; p=0.030) compared with SS PCI group.Recent European Society of Cardiology (ESC) guidelines recommended that the treatment for non-culprit lesions PCI should be considered before the discharge (class IIa, A). However,

show abstract

One-Year Clinical Outcomes between Single- versus Multi-Staged PCI for ST Elevation Myocardial Infarction with Multi-Vessel Coronary Artery Disease: from Korea Acute Myocardial Infarction Registry-National Institute of Health (KAMIR-NIH)

Cited by 5 publications

References 31 publications

2021 Korean Society of Myocardial Infarction Expert Consensus Document on Revascularization for Acute Myocardial Infarction

2021 Korean Society of Myocardial Infarction Expert Consensus Document on Revascularization for Acute Myocardial Infarction

Adjusted mortality of extracorporeal membrane oxygenation for acute myocardial infarction patients in cardiogenic shock

Optimal Timing of Coronary Intervention in Non-Culprit Lesion in ST Elevation Myocardial Infarction with Multi-Vessel Disease

Contact Info

Product

Resources

About